Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

395 studies match

clinicaltrialsPublishedShowing 51–100 of 395 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04623541	Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome(EPCORE™ CLL-1)	active not recruiting	Phase 1 / Phase 2	194	GenmabINDUSTRY	12	Sep 9, 2026	clinicaltrials
NCT05361395	First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)	active not recruiting	Phase 1	184	AmgenINDUSTRY	15	Sep 9, 2026